News & Events

News & Events

Latest

Mosaic HIV immunogens boost the breadth of vaccine immune responses
Mosaic HIV immunogens boost the breadth of vaccine immune responses
Mosaic HIV immunogens boost the breadth of vaccine immune responses
Fred Hutch,

Mosaic and consensus HIV-1 immunogen vaccines were tested in a clinical trial led by a team of researchers including Drs. Kristen Cohen, Andrew Fiore-Gartland, Peter Gilbert and M. Juliana McElrath from the Fred Hutchinson Cancer Center Vaccine and Infectious Disease Division. Their findings were published recently in the Journal of Clinical Investigation.

Andrea Rotnitzky
Andrea Rotnitzky
Internationally recognized researcher joins biostatistics faculty
Andrea Rotnitzky, a well-known biostatistician, recently joined the University of Washington School of Public Health as a professor of biostatistics.
Andrea Rotnitzky
Andrea Rotnitzky
UW faculty share $1 million Rousseeuw Prize for Statistics
Andrea Rotnitzky one of five statisticians for inaugural award in 2022.
Optogenetics illustration
Optogenetics illustration
UW-led team receives $4.2M grant to develop AI-guided brain stimulation methods aimed at treating mental health disorders
UW Electrical & Computer Engineering,

Ali Shojaie will be a member of new multidisciplinary, multi-institutional team that recently received a five-year, $4.2 million grant from the National Institutes of Health to develop neural stimulation techniques guided by artificial intelligence (AI) machine learning methods.

Ross Prentice
Ross Prentice
Fred Hutch’s Dr. Ross Prentice retires
Fred Hutch News,

Only a handful of scientists at Fred Hutchinson Cancer Center have been around longer than the institution itself; longtime public health researcher Ross Prentice, PhD, who retired at the end of 2022, is one of them.